Frontiers
US$ 20.09
glp-1 roe How GLP-1s may change the food system Ro Launches GLP-1 Insurance Coverage
Description
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity
These drugs have quickly gained popularity for their ability to deliver powerful results, where other methods have failed
Semaglutide is the name for a GLP-1-based medication manufactured by drug company Novo Nordisk
If your job is journalist, you would serve your readers and viewers better by pointing out the absolute risk reduction, and making sure you dont echo any mismatched framing
doi: 10.1097/SLE.0000000000000389
Built for: low energy, constant nausea, post-dose exhaustion, or just not wanting to cook
